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Abstract
Objectives (i) To provide a preliminary indication of the performance of phar-
macy undergraduate students and pre-registration pharmacy trainees in the
Prescribing Safety Assessment (PSA). (ii) To determine the feasibility of admin-
istering and delivering the PSA in schools of pharmacy. (iii) To examine the
potential relevance of the PSA and associated training materials to pharmacy
education. (iv) To assess the attitudes of the cohort towards the PSA and their
readiness to prescribe.
Methods Four schools of pharmacy in England recruited final year undergrad-
uate pharmacy students and pre-registration pharmacy trainees undertaking
training with both hospital and community pharmacy employers in their local-
ity to undertake the PSA. Performance data and feedback from candidates were
obtained.
Key findings Pre-registration pharmacy trainees in community (n = 27) and
hospital (n = 209) settings mean average scores were 86.3% and 85.3%, respec-
tively. There was a significant performance differential between undergraduate
pharmacy students (n = 397) and those in pre-registration training, with the
mean average score for undergraduate students being 73.0% (t test P < 0.05).
Candidates felt their current course did prepare them for the PSA, some high-
lighted that additional curriculum content would be needed should this become
a compulsory high-stakes assessment for pharmacy trainees. The majority of
candidates felt that this assessment was useful and applicable to their training.
Conclusions The PSA process and associated learning tools could be intro-
duced to pre-registration pharmacy education to support trainees in their
development towards future prescribing roles.
Introduction
Prescribing medicines is a core activity for the UK
National Health Service. Around 1 billion prescriptions
are written annually in primary care in England and
Wales, equating to an average of 18 for every member of
the population.[1] Although doctors currently write the
vast majority of prescriptions in the UK, other profes-
sional groups, including pharmacists, are able to undertake
further training and supervised practice in order to
become independent prescribers.[2]
Prescribing is a challenging task for any healthcare pro-
fessional. Prescribers have to select the correct medicine,
dosage, route and frequency of administration, sometimes
in the face of diagnostic uncertainty, taking into account
potential individual variability in drug handling and
response as a consequence of co-morbidity, genetics and
interacting drugs.[3] Given that individual patients have
different wishes, and the outcome of any prescription is
uncertain, the prescriber needs to counsel the patient and
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plan an appropriate strategy for monitoring and follow
up for evidence of benefit and harms.
Given these complexities it is perhaps not surprising
that many studies have found evidence of poor prescrib-
ing. Prescription errors amongst recent medical graduates
have been observed at a rate of 7%–10%.[4,5] There is a
lack of research examining errors made by non-medical
prescribers.[6] It is evident that there are many trends that
make prescribing increasingly demanding, including the
advanced age and vulnerability of patients, the growing
complexity of the treatment regimens and an increasingly
pressurised healthcare system. In these circumstances it is
important that new prescribers are well trained and meet
minimum standards of competency. However, studies
suggest that medical students and recent graduates often
feel underprepared for and anxious about prescribing,[4,7]
a concern echoed by their supervisors.[8]
In response to these concerns, the British Pharmacologi-
cal Society and Medical Schools Council developed and
introduced the Prescribing Safety Assessment (PSA) with
the intention of enabling final year medical students to
demonstrate that they have the necessary knowledge and
skills to prescribe and supervise the use of medicines at
the standard expected of a foundation doctor in an NHS
hospital.[9] The PSA was first piloted in 2010, and by
2014 was taken by all final year UK medical students. All
medical schools in the UK participate, along with five in
Ireland and one in Malta. The PSA is held in medical
schools between February and June each year. Passing the
PSA is now an essential part of successful completion of
the foundation training year for newly qualified doctors.
The vast majority of medical students, by preparing for
and undertaking this assessment, have now been found to
meet a pre-specified standard of prescribing competence
before entering clinical practice.[10]
Pharmacists constitute a significant part of the NHS
workforce and are highly trained in all aspects of medici-
nes use. Currently, the route to registration as a pharma-
cist involves completion of a General Pharmaceutical
Council (GPhC) accredited 4-year MPharm degree and
1 year of pre-registration training or a 5-year MPharm
degree with integrated pre-registration training, followed
by successful completion of the GPhC’s registration
assessment.[11] In order to qualify as an independent pre-
scriber, pharmacists with a minimum of 2 years experi-
ence must complete a GPhC accredited programme,
typically run over 6–12 months. Pharmacist independent
prescribers can prescribe autonomously within their area
of clinical competence.[12] The demand for pharmacist
prescribers is increasing in line with the recommendations
of Lord Carter’s Review of Productivity in Hospitals.[13]
In addition the Five Year Forward View[14] and GP For-
ward View[15] both set out Government plans to develop
a prescribing pharmacy workforce undertaking patient
facing roles in general practice. It is expected that in the
future prescribing will become a standard element of
career progression for all pharmacists in clinical roles.
Both the English Department of Health and the Scot-
tish Government have signalled their interest in pursuing
a scenario in which pharmacists will be independent pre-
scribers by virtue of their primary registration.[16] To
explore this, the Pharmacy Education Reform team
undertook a small scale trial of the PSA with pharmacy
undergraduates and pre-registration trainees in 2015.[17]
This reported a positive outcome and recommended that
a second pilot trial of the PSA with larger cohorts should
take place.
Aims
The purpose of this pilot study was to investigate the
application of the PSA to pre-registration pharmacists
and undergraduate (MPharm) pharmacy students. The
specific aims were:
(i) To provide a preliminary indication of the perfor-
mance of pharmacy undergraduates and pre-registra-
tion pharmacy trainees in the PSA.
(ii) To determine the feasibility of administering and
delivering the PSA in schools of pharmacy.
(iii) To examine the potential relevance of the PSA and
associated training materials to pharmacy education.
(iv) To assess the attitudes of the cohort towards the PSA
and their readiness to prescribe.
Methods
Recruitment of candidates
All English schools of pharmacy were invited to partici-
pate in this pilot by Health Education England. Four
schools of pharmacy volunteered to take part and subse-
quently invited final year pharmacy students (n = 500)
and local pre-registration trainees (n = 250) from com-
munity and hospital settings to take part in this study.
The involvement of candidates was voluntary and their
consent to use the data obtained to inform developments
in pharmacy education was obtained. Assessments were
run between 25 April 2016 and 19 May 2016 on 4 dates;
dates were agreed by the PSA team and Universities with
the aim being to limit the numbers of dates used.
PSA structure
The PSA is based on the competencies identified in the
General Medical Council’s Outcomes for graduates (origi-
nally published in Tomorrow’s Doctors[18]), such as
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writing new prescriptions, reviewing existing prescrip-
tions, calculating drug doses, identifying and avoiding
both adverse drug reactions and medication errors and
amending prescribing to suit individual patient circum-
stances. Each PSA comprises eight distinct sections: pre-
scribing (PWS), prescription review (REV), planning
management (MAN), providing information about
medicines (COM), calculation skills (CAL), adverse drug
reactions (ADR), drug monitoring (TDM) and data inter-
pretation (DAT). These are covered in 60 question items
that have to be completed over 2-h (candidates allowed
reasonable adjustments are given an additional 30 min)
(Figure 1). The content of each question relates to dis-
eases and medicines that foundation doctors are likely to
encounter in the early stages of their postgraduate train-
ing. A range of question styles are used including free-text
and multiple choice formats.[9]
The PSA used for the pharmacy pilot events had been
previously validated and standard set for use in medical
education. The assessment consisted of 30 questions to be
taken over 60 min. To aid feasibility of delivery of this
pilot study the assessment was shorter than that currently
used in medical education but was at the same level of dif-
ficulty in terms of both content and the clinical reasoning
skills required. The items had been through the quality
assurance and approval processes of the standard PSA, but
had been retired from secure high-stakes usage, and so
were available for use in this pilot. The only modification
to the assessment build was the replacement of an item
requiring an intravenous fluid prescription with a second
item requiring a prescription to be written on a general
practice prescription form. The distribution of the clinical
settings of the case scenarios are illustrated in Table 1.
Candidate preparation
All volunteer candidates were registered on the PSA
online system and sent an e-mail requesting them to acti-
vate their accounts. After registration they then had access
to general information about the PSA, 12 orientation
videos and four 1-h practice ‘papers’.
Delivery of the PSA events
Each PSA event was delivered live online to each location
under invigilated conditions. After logging into the PSA
system candidates were given a unique event-specific pass-
word that allowed them to enter the 30-item assessment
described above. All participants had access to the online
BNF and calculator throughout the assessment. The can-
didates had 1-h to complete the assessment.
Post-assessment review
All prescriptions written by the candidates were scruti-
nised immediately after the assessment (‘post-assessment
review’) to ensure that the answer matrix for the prescrib-
ing items took into account any creditworthy responses
that had not already been anticipated. The PSA system
automatically identifies all unrecognised drugs and
Figure 1 Structure of the Prescribing Safety Assessment (PSA).
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unrecognised drug order sentences that have been pro-
vided by candidates. These were carefully reviewed by the
PSA team and appropriate scores allocated and added to
the electronic marking scheme. This allows the candi-
dates’ marks to be automatically updated.
Feedback questionnaire
After exiting the assessment, all candidates were immedi-
ately taken to a standard feedback form designed for all
PSA candidates. This asked the students if there were any
items which were unclear or perceived to be beyond their
scope of learning. Students were also asked to comment on
how they felt the PSA test could be improved and to rate
on a likert scale statements including the following: ‘My
course prepared me for the content of this assessment’.
Data analysis
Thematic analysis of the student feedback was under-
taken. The performance data was analysed using SPSS
and the t-test. This was this was used to compare perfor-
mance between MPharm students and pre-registration
trainees and between trainees based in hospital and com-
munity pharmacy settings.
Ethical approval
This evaluation of the PSA in pharmacy education was
undertaken as part of wider Heath Education England
service development, ethical approval was sought and
obtained.
Results
Candidates
Pre-registration trainees based both in community
(n = 27) and hospital settings (n = 209) and 397
MPharm students undertook the assessment.
Candidate performance
MPharm students achieved an average mark of 73.0% (range
13%–93%). Pre-registration trainees based in a community
setting achieved an average mark of 86.3% (range 63%–96%)
and those in a hospital setting 85.3% (range 43%–98%).
There was a significant difference in overall performance
between undergraduate pharmacy students and those in pre-
registration training (t test P < 0.05), in all question types
except those involving calculations (CAL) where no perfor-
mance differential was found. Community pharmacy pre-
registration trainees performed better than those trained in
hospital in providing information (COM) questions (t test
P < 0.05) and planning and management (MAN) questions
(t test P < 0.05). There was no other significant difference in
performance between hospital and community pharmacy
pre-registration trainees. Overall both MPharm students and
pre-registration students performed best in calculation (CAL)
questions (t-test MPharm P < 0.05 Pre-registration < 0.05)
and worst in data interpretation (DAT) questions (t-test
MPharm P < 0.05 Pre-registration P < 0.05).
Candidate feedback
Most candidates (71%) either agreed or strongly agreed
with the statement ‘My course prepared me for the con-
tent of the questions in this assessment’ on completion of
it. Thematic analysis was performed on further feedback
obtained from the candidates. Three key themes emerged:
Acceptance
Candidates were overwhelmingly accepting of the PSA as
a method of assessing their knowledge and skills. They felt
it was useful and realistic:
It was useful to prepare for my exams. I find it
easier to learn by applying the knowledge to case
studies than just to read knowledge so this was use-
ful and enjoyable (MPharm student)
Very realistic. . .probes for real life situations (Pre-
registration trainee)
Pharmacy students should have more access to ques-
tions like this throughout the course and then it may
prepare them better for “real life” (MPharm student)
Content
The majority of candidates reported that the content of
the assessment was relevant and applicable to their train-
ing and future professional roles:
Table 1 The distribution of the cases included in the abbreviated
PSA according to clinical setting
Clinical setting Number of items
Medicine (MED) 9
Surgery (SURG) 1
Elderly care (ELD) 2
Paediatrics (PED) 1
Psychiatry (PSYCH) 3
Obstetrics and Gynaecology (O&G) 2
General practice (GP) 12
Total 30
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Everything tested was reasonable and the partici-
pant should be expected to know at this level
(MPharm student)
However, a minority of MPharm students reported that
their course had not prepared them to undertake prescrib-
ing tasks and did not recognise the relevance of prescrib-
ing skills to their future practice. There were particular
comments about questions relating to fluids prescribing.
This feedback was considered and addressed by the PSA
team during the post assessment review process.
Haven’t really been taught about fluid or inpatient
treatment charts, so more info[rmation] would be
needed on these if this was a regular part of the
assessment schedule (MPharm student)
Range of long term therapies vs acute management
[should be included]. De-prescribing as well as pre-
scribing (i.e. rationalising medication at end of life)
(Pre-registration trainee)
Some students and trainees would have liked access to
mock tests throughout the year. Pre-registration trainees
reported that undertaking the PSA was useful in relation to
their preparation to sit the GPhC registration assessment:
Very useful in further developing my knowledge of
prescribing and for the GPharmC exam, continue
involving pharmacists (Pre-registration trainee)
Feasibility and logistics
Feedback was very positive in terms of preparation, layout
and timing of the assessment. Some candidates felt they
needed more time but this was balanced with those that
felt there was adequate. This may reflect a lack of famil-
iarity with resources particularly the electronic BNF. Some
candidates were unfamiliar with hospital prescribing
charts. Candidates commented on when and where this
assessment should be located if it were to be incorporated
into pharmacy training:
I think it would be a good idea to incorporate this
into pharmacy pre-registration training as part of
core skills training (Pre-registration trainee)
I think final year students should take the PSA at
the beginning of the year just before they sit their
final exams. This will help reflect progress with
regards to knowledge gained throughout the entire
MPharm course (MPharm student)
MPharm students were also positive but a number
commented that exam periods should be avoided when
considering the timing of the assessment.
Feedback from institutions hosting the
assessment
Feedback from University staff was very positive. Support
from the PSA team was excellent in terms of pre assessment
preparation, administration of the assessment on the day
and post assessment provision of results. Some Universities
had minor IT challenges, for example, registering pre-regis-
tration trainees with University logins. No issues had any
impact on the successful running of the assessment.
One university reported very low MPharm attendance
and two others noted disengagement from some MPharm
students who subsequently left the assessment early (perfor-
mance data from these students is included in the overall
data set). Organisers stated that scheduling the assessment
so that it was co-hosted alongside a preregistration phar-
macist study day increased the number of pre-registration
pharmacists attending substantially. However it was also
noted that one community pharmacist employer was
unable to send trainees due to a clash of dates, and there-
fore, even earlier notice of assessment dates would be
advantageous moving forward. Earlier access to past papers
to support student preparation was also requested. Univer-
sities and Health Education England expressed their com-
mitment to further future engagement with the PSA.
Discussion
The aims of this study were to assess the performance of
pharmacy trainees in the PSA; the feasibility of its deliv-
ery; its relevance to pharmacy training and the attitudes
of pharmacy trainees towards this assessment.
Performance
Pharmacy pre-registration trainees had less variation in their
marks compared to MPharm students and overall scored
more highly. This suggests that the practical clinical exposure
gained during the pre-registration training year confers an
advantage when undertaking this assessment. This is note-
worthy as discussions continue with regards to how phar-
macy trainees can be equipped to undertake prescribing roles
and where in training programmes prescribing assessments
should be located. Further testing with larger cohorts is
required to be able to draw any firm conclusions about varia-
tion across question domains and to inform future discussion
about curriculum and assessment design for these trainees.
Feasibility of delivering the PSA within
pharmacy training
This pilot study has shown that it is feasible to deliver the
PSA to large numbers of pharmacy students across a number
International Journal of Pharmacy Practice 2018, , pp. – © 2018 The Authors. International Journal of Pharmacy Practice
published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society
Jessica Hardisty et al. 5
of institutions and that local networks can be utilised to sup-
port pre-registration trainees to undertake the assessment.
Pharmacy pre-registration differs from medical training in
that it is delivered by both NHS and non-NHS private sector
employers (although contracted to provide NHS services).
While on a small scale, in this study the PSA was delivered to
pre-registration trainees based in all sectors and across all
employer types. It would be feasible to incorporate the PSA
into undergraduate pharmacy training within current deliv-
ery models including integrated 5-year programmes.
Relevance of the PSA to pharmacy training
Overall candidates undertaking the PSA felt it was rele-
vant and applicable to their training, describing it as use-
ful, practical and confidence giving. MPharm students felt
their current course did prepare them for some aspects of
the PSA but that additional content would be needed
should this become a compulsory high-stakes assessment
for pharmacy students. Some pharmacy students do not
acknowledge the relevance of prescribing skills to their
future practice. This highlights a wider issue which needs
to be addressed by educators if advanced clinical roles for
pharmacists are to be expanded and integrated into the
wider healthcare system.
Attitudes of pharmacy students to the PSA
Students were accepting of the PSA and engaged in
preparing for and undertaking it. It is noted that the stu-
dents in this study were largely (although not entirely) a
self-selecting group and that the minority who raised
questions about the relevance of prescribing to their
future roles may be greater in number should the PSA
become a compulsory component of pharmacy training.
Weaknesses of the study
There are some important limitations that must be
acknowledged when interpreting the performance data.
The size of the cohort was small and may not be repre-
sentative of the larger group of pharmacy trainees since
this was a self-selected and possibly highly motivated
cohort of individuals. The motivation of the candidates
was also uncertain given that they were all volunteers for
whom there were no significant implications attached to
their performance in this pilot.
Conclusion
This study aimed to assess if a current tool, the PSA, used
to prepare medical students for prescribing roles has a
future utility in pharmacy education. The results show
that the PSA was feasible and acceptable to pharmacy
trainees and their educators. It must however be noted
that evidence from the training of doctors shows that
educational interventions alone do not prevent prescrib-
ing errors in clinical practice. Significant clinical exposure
and opportunities to practice the complex task of pre-
scribing in advance of taking on this role must be facili-
tated. Feedback from Universities highlighted that the
PSA results can be used to inform curriculum develop-
ment, particularly the detailed feedback about perfor-
mance in individual domains.
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